Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/CATALENT-INC-17083784/news/EU-Aufsichtsbehorde-pruft-Verfugbarkeit-von-Medikamenten-die-in-Catalent-Werken-hergestellt-und-45905237/?utm_source=whatsapp&utm_medium=social&utm_campaign=share